Maxcyte (MXCT) Free Cash Flow (2020 - 2026)
Maxcyte (MXCT) posted quarterly Free Cash Flow of -$8.2 million for Q1 2026, up 45.29% year-over-year from -$5.7 million in Q1 2025, and down 231.1% quarter-over-quarter from -$2.5 million in Q4 2025.
Maxcyte (MXCT) Free Cash Flow (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Free Cash Flow for 7 consecutive years, with -$8.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 45.29% year-over-year to -$8.2 million; the TTM figure through Mar 2026 stood at -$28.3 million (up 12.19% YoY), while the FY2025 annual figure was -$35.1 million, down 26.81% from the prior year.
- Free Cash Flow declined to -$8.2 million in Q1 2026 per MXCT's latest filing, from -$2.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $6.3 million in Q2 2022 and bottomed at -$23.7 million in Q4 2022.
- Historically, Free Cash Flow has averaged -$7.4 million across 5 years, with a median of -$7.9 million in 2024.
- On a YoY basis, Free Cash Flow climbed as much as 205.1% in 2022 and fell as far as 1037.64% in 2022.
- Maxcyte's Free Cash Flow stood at -$23.7 million in 2022, then surged by 113.51% to $3.2 million in 2023, then tumbled by 346.34% to -$7.9 million in 2024, then surged by 68.43% to -$2.5 million in 2025, then tumbled by 231.1% to -$8.2 million in 2026.
- Business Quant data shows MXCT's Free Cash Flow at -$8.2 million in Q1 2026, -$2.5 million in Q4 2025, and -$7.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | -3.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.09 Mn |
| Jun 30, 2026 | -3.09 Mn |
| Mar 31, 2026 | -8.24 Mn |
| Mar 31, 2026 | -8.24 Mn |
| Dec 31, 2025 | -2.49 Mn |
| Dec 31, 2025 | -2.49 Mn |
| Sep 30, 2025 | -7.15 Mn |
| Sep 30, 2025 | -7.15 Mn |
| Jun 30, 2025 | -10.44 Mn |
| Jun 30, 2025 | -10.44 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Dec 31, 2024 | -7.88 Mn |
| Dec 31, 2024 | -7.88 Mn |
| Sep 30, 2024 | -4.35 Mn |
| Sep 30, 2024 | -4.35 Mn |
| Jun 30, 2024 | -4.95 Mn |
| Jun 30, 2024 | -4.95 Mn |
| Mar 31, 2024 | -10.53 Mn |
| Mar 31, 2024 | -10.53 Mn |